Department of Medicine 5 – Haematology and Oncology

Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot (2021) Agaimy A, Meidenbauer N, Sukov WR, Stöhr R, Vieth M, Roemer F, Grützmann R, Folpe AL Journal article β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression (2021) Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, Büttner-Herold M, Bach C, Spriewald B, et al. Journal article CD19-targeted CAR T cells in refractory systemic lupus erythematosus (2021) Mougiakakos D, Krönke G, Völkl S, Kretschmann S, Aigner M, Kharboutli S, Böltz S, et al. Journal article Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9+ T Cells (2021) Majumder S, Jugovic I, Saul D, Bell L, Hundhausen N, Seal R, Beilhack A, et al. Journal article Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: A case report (2021) Jitschin R, Kharboutli S, Stoll A, Büttner-Herold M, Schmidt D, Rösler W, Mackensen A, et al. Journal article Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens (2021) Bernhardt AL, Zeun J, Marecek M, Reimann H, Kretschmann S, Bausenwein J, van der Meijden E, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy (2021) Wennerberg E, Lundqvist A, Mao Y, Mougiakakos D Journal article Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy (2021) Reimann H, Nguyen A, Sanborn JZ, Vaske CJ, Benz SC, Niazi K, Rabizadeh S, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article